Sava Infond d.o.o.
Source: SEC Form 13F · as of Mar 2026Sava Infond d.o.o. holds 23 biotech & pharma companies tracked by BioSniper, totaling $52.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$52.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 9,110 | $8.4M |
| AZNASTRAZENECA PLC | 41,890 | $8.1M |
| MRKMerck & Co., Inc. | 53,620 | $6.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 19,510 | $5.3M |
| JNJJOHNSON & JOHNSON | 18,545 | $4.5M |
| ELVElevance Health Inc. | 10,360 | $3.0M |
| ABTABBOTT LABORATORIES | 29,540 | $3.0M |
| IQVIQVIA Holdings Inc. | 15,910 | $2.7M |
| ABBVAbbVie Inc. | 10,846 | $2.4M |
| ZTSZoetis Inc. | 11,700 | $1.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,670 | $1.3M |
| AMGNAMGEN INC | 2,650 | $932K |
| RPRXRoyalty Pharma plc | 18,860 | $905K |
| JAZZJazz Pharmaceuticals plc | 4,200 | $794K |
| NVONovo Nordisk A/S | 20,725 | $762K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,550 | $692K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,285 | $425K |
| PFEPFIZER INC | 14,600 | $410K |
| GILDGILEAD SCIENCES, INC. | 2,740 | $382K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 3,250 | $184K |
| BIIBBIOGEN INC. | 825 | $151K |
| RGENREPLIGEN CORP | 1,200 | $141K |
| IDXXIDEXX LABORATORIES INC /DE | 180 | $101K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.